Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that its subsidia ...

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome ...

Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) will likely be posting its quarterly earnings results before the market ...

Acrivon Therapeutics, Inc.’s ACRV share price has dipped by 30.24%, which has investors questioning if this is right time to ...

The CellScape™ Precise Spatial Proteomics platform is a cutting-edge imaging solution for quantitative in situ spatial phenotyping. The CellScape platform enables highly multiplexed spatial proteomics ...

At the core of Acrivon’s innovative approach is its AP3 (Acrivon Predictive Precision Proteomics) platform. This technology has garnered attention for several reasons: It offers a unique method ...

Equities research analysts at HC Wainwright issued their FY2029 earnings estimates for Acrivon Therapeutics in a report issued on Wednesday, March 26th. HC Wainwright analyst E. Bodnar anticipates ...

Shidong Wang is a leading expert in the life sciences industry, currently serving as the Associate Director of Life Sciences ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce ...

Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company ™, announces the start ...